Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (101-110 of 429) with videos related to

Pageof 43
Sort By:
Annals of Surgical Oncology|June 29, 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesisTari A King, Weiwei Li, Edi Brogi, et al.
Breast Cancer Research and Treatment|November 3, 2016
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer familyCiyu Yang, Angela G Arnold, Magan Trottier, et al.
Journal of the National Cancer Institute|September 22, 2005
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer familiesNoah D Kauff, Nandita Mitra, Mark E Robson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 29, 2010
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancerRobert J Klein, Christer Halldén, Angel M Cronin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma RiskMyvizhi Esai Selvan, Marjorie G Zauderer, Charles M Rudin, et al.
Cancer|June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-upNoah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2022
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and OpportunitiesKenneth Offit, Catherine M Sharkey, Dina Green, et al.
Pageof 43

Showing results (101-110 of 429) with videos related to

Sort By:
Pageof 43
Annals of Surgical Oncology|June 29, 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesisTari A King, Weiwei Li, Edi Brogi, et al.
Breast Cancer Research and Treatment|November 3, 2016
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer familyCiyu Yang, Angela G Arnold, Magan Trottier, et al.
Journal of the National Cancer Institute|September 22, 2005
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer familiesNoah D Kauff, Nandita Mitra, Mark E Robson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 29, 2010
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancerRobert J Klein, Christer Halldén, Angel M Cronin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma RiskMyvizhi Esai Selvan, Marjorie G Zauderer, Charles M Rudin, et al.
Cancer|June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-upNoah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2022
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and OpportunitiesKenneth Offit, Catherine M Sharkey, Dina Green, et al.
Pageof 43